1832 Asset Management
UTHR icon

1832 Asset Management’s United Therapeutics UTHR Stock Holding History

1832 Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,844
Closed -$4.06M – 709
2026
Q1 		$4.06M Sell
6,844
-4,038
-37% -$2.01M ﹤0.01% 449
2025
Q4 		$5.3M Buy
10,882
+6,427
+144% +$2.99M ﹤0.01% 434
2025
Q3 		$1.87M Sell
4,455
-525
-11% -$177K ﹤0.01% 511
2025
Q2 		$1.43M Sell
4,980
-292
-6% -$87.3K ﹤0.01% 539
2025
Q1 		$1.63M Sell
5,272
-186
-3% -$63.7K ﹤0.01% 510
2024
Q4 		$1.93M Buy
5,458
+211
+4% +$77.6K ﹤0.01% 497
2024
Q3 		$1.88M Buy
5,247
+343
+7% +$116K ﹤0.01% 539
2024
Q2 		$1.56M Buy
+4,904
New +$1.3M ﹤0.01% 536
2018
Q3 		– Sell
-30
Closed -$4K – 720
2018
Q2 		$4K Hold
30
– – ﹤0.01% 618
2018
Q1 		$3K Sell
30
-185
-86% -$23.5K ﹤0.01% 643
2017
Q4 		$32K Sell
215
-295
-58% -$37.5K ﹤0.01% 571
2017
Q3 		$60K Buy
510
+18
+4% +$2.3K ﹤0.01% 569
2017
Q2 		$64K Buy
492
+12
+3% +$1.5K ﹤0.01% 540
2017
Q1 		$65K Sell
480
-95
-17% -$14.4K ﹤0.01% 579
2016
Q4 		$83K Buy
+575
New +$73.4K ﹤0.01% 556

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

1832 Asset Management's UTHR Position: Q2 2026 in Review

1832 Asset Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 6,844 shares — an estimated $4.06M sold.

1832 Asset Management first reported a position in UTHR in Q4 2016 and held it in 15 quarters. The position peaked at $5.3M in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • 1832 Asset Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • 1832 Asset Management sold 6,844 United Therapeutics shares in Q2 2026, an estimated $4.06M.
  • 1832 Asset Management first reported a position in United Therapeutics in Q4 2016 and held it in 15 quarters.
  • 1832 Asset Management's United Therapeutics position peaked at $5.3M in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.